An Open-label Study of SG1827 in Subjects With Advanced Solid Tumors
Clinical trial NCT06076291 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06076291
- Sponsor
- Hangzhou Sumgen Biotech Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-27
- Primary completion
- 2026-03-18
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.